Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen, Qiagen Ink Co-Marketing Agreement in Japan

NEW YORK (GenomeWeb News) — WaferGen Biosystems and Qiagen KK, the Japanese subsidiary of Qiagen, said today that they have inked a co-marketing agreement for genomics products.

Under the agreement, Qiagen and WaferGen will promote each other's products in Japan. In particular, the companies will co-market WaferGen's SmartChip Real-Time PCR system and Qiagen's PCR arrays and next-generation sequencing platform, the latter of which is currently in an "advanced stage of development," the companies said.

The purpose of the relationship is to help life science researchers more quickly develop and validate biomarkers that are potential candidates for molecular diagnostics by using WaferGen's SmartChip system, the companies said.

Last June, Qiagen acquired next-generation sequencing firm Intelligent Bio-Systems, noting at the time that it planned to develop the company's sequencing technology for the molecular diagnostics and clinical research markets.

Qiagen said today that the forthcoming sequencing platform is one element of an initiative to create "integrated NGS workflows that combine innovative instrumentation and consumables into a sample-to-result offering" planned for launch later this year.

WaferGen's SmartChip platform is designed to profile and validate thousands of molecular biomarkers in parallel and performs high-throughput microRNA and mRNA gene expression profiling and SNP genotyping.

"There is a substantial customer need to ramp up discovery efforts through targeted screening and confirmation, and our integrated approach will provide one-stop shopping for a variety of academic and industrial clients," Stephane Perrey, president of QIAGEN KK, said in a statement.

Financial terms of the agreement were not disclosed.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.